A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan

Takeda

Status: Completed

Conditions: Multiple Myeloma

Treatments: Other: No Intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT05882279

C16065

Details and patient eligibility

About

This is a survey among pharmacists who have instructed NINLARO therapy in ixazomib, lenalidomide and dexamethasone (IRD) dosing to patients with relapsed/refractory multiple myeloma (rrMM).

The main aims of the study are:

• To assess the frequency of pharmacists who have provided patients with the contents of the RMP material for patients.
• To assess the frequency of pharmacists who have obtained the RMP material for patients.
• To evaluate the depth of understanding of proper usage of NINLARO among pharmacists.

Full description

This is a prospective, non-interventional, observational web-based survey in pharmacists who have instructed the dosing of NINLARO (ixazomib) in combination with lenalidomide and dexamethasone therapy to patients with rrMM. The study will assess the effectiveness of distributed RMP material in prevention of ixazomib overdose in Japanese clinical practice.

The study will enroll approximately 300 pharmacists who belong to hospitals prescribing NINLARO. The data will be collected through a self-administered web-based survey with questionnaires provided in Japanese.

This web-based survey will be conducted in Japan.

Enrollment: 330 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Who belong to hospitals prescribing NINLARO.
2. Who have instructed the dosing of NINLARO in IRD therapy to patients.

Exclusion criteria

None

Trial design

330 participants in 1 patient group

Pharmacists in Hospitals Prescribing NINLARO

Description:

Pharmacists included in Nikkei Research Access Panel who are active in clinical practice, with valid contact and who have instructed the dosing of NINLARO IRD therapy to patients with rrMM will self-administer a web-based survey. The questionnaires in the survey will be provided in Japanese.

Treatment:

Other: No Intervention